Price $110.80 |
Market Cap
190.99B
|
Sector Health Care |
Div. Growth
10.30%
|
|
P/E
40.0
|
P/B
14.68
|
P/S
4.19
|
Dividend %
4.80%
|
|
P/CF
-
|
P/FCF
20.6
|
Op. Cash Flow
17.59M
|
FCF
5.2
|
|
Op. Margin
24.80%
|
Net Margin
9.90%
|
ROE
51.10%
|
ROI
12.70%
|
|
ROA
3.40%
|
EPS Growth
-48.70%
|
Current Ratio
0.8
|
Debt/Equity
593.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ImmuCell Corporation (ICCC) | $8.65 | - | - | 69.5M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $66.08 | - | 3.10% | 141.03B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.11 | - | - | 12.5B | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.97 | - | - | 45.2M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $5.81 | - | - | 2.02B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
